Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

January 11, 2023
BioUtah News
Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding

ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal funding.

January 10, 2023
BioUtah News
Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health

Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility

January 10, 2023
BioUtah News
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems

Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease

January 10, 2023
BioUtah News
Fluidx Unveils New Embolic for Neurovascular Use

New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain

January 5, 2023
BioUtah News
Nomi Health Hires Global Health and Technology Leader Amy Wykoff as Company’s First Chief Product Officer

Wykoff to build upon more than two decades of public and private sector healthcare leadership to head up delivering Nomi Health’s core business offerings

December 21, 2022
Policy News
HEALTHCARE POLICY FIGURES PROMINENTLY IN $1.7 TRILLION OMNIBUS GOVERNMENT FUNDING BILL

Congress is expected to vote this week on a massive omnibus government funding bill that would run through the end of the 2023 fiscal year. The legislative text was released on Tuesday. The $1.7 trillion, 4,155-page bill includes a number of significant healthcare provisions. Of particular interest to the life sciences industry are provisions included […]

December 21, 2022
BioUtah News
IONIQ is “Clinical Diagnostics Solution of the Year 2022”

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

December 20, 2022
BioUtah News
IONIQ Science 2022 year-end update

For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]

December 15, 2022
BioUtah News
2022 BIO Report Ranks Utah in the Top Eight States for Bioscience Specialization

The 2022 TEConomy/BIO report, The US Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, examines the bioscience industry’s impact on the national economy and provides state specific data, with Utah and its major metropolitan areas ranking high in specialized employment concentration in three major subsectors – medical device manufacturing, pharmaceuticals, research, testing and medical laboratories […]

December 14, 2022
BioUtah News
Participate in Life Sciences Day on the Hill

The annual Life Sciences Day on the Hill provides our industry with the opportunity to get face time with legislators and other government officials during the 2023 legislative session. Slated for Friday, January 27, 2023 from 11:00 AM to 2:00 PM, the event permits BioUtah members to demonstrate their important breakthroughs, devices and innovations. It […]

December 8, 2022
BioUtah News
Stryker launches state-of-the-art Neurovascular R&D lab with advanced technology to accelerate stroke care innovation

Stryker, one of the world’s leading medical technology companies, recently opened its Neurovascular (NV) lab, a state-of-the-art lab designed to accelerate stroke-related innovation in Asia Pacific. Located within the Stryker Global Technology Center (SGTC) at International Park, Gurgaon, India, the Keystone Suite will enable collaboration between customers, product development engineers, cross-functional teams, and other key […]

December 7, 2022
BioUtah News
Merrimack provides Ipsen report that Onivyde® regimen demonstrated statistically significant improvement in overall survival in previously untreated metastatic pancreatic ductal adenocarcinoma

Cambridge, MA, November 9, 2022 /Business Wire/ – Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] announced that Ipsen, SA (“Ipsen”) issued a press release today reporting its primary analysis of the results of its Phase III NAPOLI 3 trial of Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) as a […]

December 1, 2022
BioUtah News
Utah Life Sciences Companies participate in Utah Trade Delegation to Medica 2022

Exhibiting their innovative products and services to over 80,000 visitors, 11 life science companies represented Utah at the MEDICA trade show in Düsseldorf, Germany. Looking across the global landscape of innovative healthcare products, Charlotte Serage, WTC Utah’s manager of trade shows and trade missions, said, “It’s clear that Utah is a major player.” Shoutout to EVŌQbio, Matia Mobility, NanoSpot.ai, SINTX […]

December 1, 2022
BioUtah News
Halia Therapeutics Presents at 4th Inflammasome Therapeutics Summit

SALT LAKE CITY–(BUSINESS WIRE)–Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by chronic inflammation, was invited to present today at the 4th Inflammasome Therapeutics Summit. Dr. David J. Bearss, CEO of Halia Therapeutics, will chair a panel entitled, “Advances in Proof-of-Concept Trials & Moving Towards the Clinic,” and also […]

December 1, 2022
BioUtah News
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023

LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal first quarter ended September 30, 2022. Recent […]

December 1, 2022
BioUtah News
Ortho Development Launches Enabling Technology for Total Knee

by Julie A. Vetalice Ortho Development BKS Total PSI has been released for commercial distribution in the United States in collaboration with Materialise, a provider of additive manufacturing software and 3D printing solutions. BKS Total PSI is compatible with Ortho Development’s BKS and BKS TriMax total knee replacement systems. BKS Total PSI, powered by Materialise, […]

November 30, 2022
BioUtah News
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654

November 22, 2022
Policy News
Sen. Lee Introduces Bill to Increase Patient Access to Biosimilars

On November 17, Sen. Mike Lee (R-UT) introduced the “Biosimilar Red Tape Elimination Act” to increase patient access to biosimilars and reduce costs by easing switching studies required to allow a biosimilar to be substituted for a biologic. View a one-page summary HERE. Currently, pharmacists can substitute generics in lieu of their branded counterparts without […]

November 22, 2022
BioUtah News
NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES

The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE

November 21, 2022
BioUtah News
Teva Announces Appointment of Richard Francis as President and CEO

Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future

November 17, 2022
BioUtah News
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information

SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the launch of UroSuite, a comprehensive suite of genetic risk assessment tests that cover every stage of prostate cancer care. UroSuite includes Myriad’s Prolaris® Prostate Cancer Test, MyRisk™ Hereditary Cancer Test, […]

November 15, 2022
BioUtah News
CenExel Creates Clinical Sciences Business Unit

CenExel announces a new Clinical Sciencesbusiness unit and more.

November 12, 2022
BioUtah News
BioHive Summit Recap

On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented by Mayer Brown. It was the first time in three years the industry had gathered in person. The pent up demand for in-person networking combined with quality programming resulted in record registration of over 700 participants. Governor […]

November 11, 2022
BioUtah News
Betty Iverson Retirement

Betty Iverson Retirement Announced